Happy Friday the 13th, everybody!
GPs flush with capital paired with pent up supply of has lent to a crazy pace of dealmaking in recent days. Those working toward a year-end close have a limited amount of time now to sign up their deals in order to get through the HSR waiting period of 30 days.
The year-end M&A rush isn’t unusual, but how much of activity should be attributed to the backlog created from covid? Or the election outcome? Send me your thoughts.
One brewing deal to watch for involves Great Hill’s Quantum Health, a rapidly-growing business that helps employees navigate their healthcare benefits. Final bids for the business are due today, I learned this week.
While the self-insured employer benefits arena has surfaced as an increasingly hot area of investment, Quantum in particular has seen interest accelerate in part due to the strong performance of its publicly traded peer, Accolade – which trades at a low teens revenue multiple. Check out my full report for finanical metrics and more.
Betting on growth: Elsewhere, Carlyle made a more than $250 million strategic investment in Pharmapacks, an ecommerce enablement platform and retail seller for brands across major ecommerce marketplaces like Amazon, Walmart and eBay.
Pharmapacks is on a current run rate to achieve approximately 60 percent year-over-year growth, the announcement said.
For Carlyle, the deal comes on the heels of its majority acquisition of Morgan Stanley Capital Partners’ Manna Pro, a manufacturer of pet health and wellness products.
That’s it for me today. As always, write to me at firstname.lastname@example.org with any tips, feedback or just to say hello.